Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_assertion wasGeneratedBy ECO_0000203 NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_assertion wasDerivedFrom befree-20140225 NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_assertion SIO_000772 22012255 NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_assertion evidence source_evidence_literature NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_assertion description "[Collectively, these findings suggest that the combination of Hsp27 knockdown with OGX-427 and chemotherapeutic agents such as gemcitabine can be a novel strategy to inhibit the progression of pancreas cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP256366.RAlYv-WeiXt2f214nk34JzV2xpZfjO9UcU9NYjBWQAUqQ130_provenance.